Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study that saw some participants achieving an 88.94% reduction in viral load. The Japanese ...

Sanofi’s jump in earnings comes with an increased emphasis on R&D and vaccines, plus an eye cast toward M&A to shore up its pipeline.

The FDA will review a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

GSK (GSK) announced that the European Medicines Agency, EMA, has accepted for review the regulatory application of a prefilled syringe ...

Influenza Vaccines Market is estimated to valued at USD 8.30 Bn in 2024 and is expected to reach USD 13.43 Bn by 2031, exhibiting CAGR of 7.1% from 2024-2031 BURLINGAME, CA, UNITED STATES ...

Additionally, just 44.5% of adults ages 75 and older have received the RSV vaccine, according to CDC data. A health professional is seen vaccinating a person. STOCK PHOTO/Adobe Stock Nearly half ...

Additionally, just 44.5% of adults ages 75 and older have received the RSV vaccine, according to CDC data. Nearly half of all children are vaccinated against the flu at 42.9%, but just 11% have ...

(WLUK) -- Wisconsin health officials confirmed the first pediatric influenza-associated death in the state for the 2024-2025 season. "We are saddened to announce the season's first death of a ...